🔰Fructose, Fatty Liver & Diabetes: Can Unani Medicine Offer a Different Metabolic Map?

“Sugar is sugar.”

Modern metabolic research tells us: not exactly.

Fructose is handled predominantly by the liver, and experimental and human evidence suggests it can stimulate hepatic de novo lipogenesis more strongly than glucose—particularly in the setting of excess intake and metabolic dysfunction.

But here is where an Applied Unani research question becomes fascinating:

What if we stop looking at diabetes as merely a “blood sugar disease”?

In Unani physiology, digestion is not simply food → glucose.

There is a sequential process:

Meda → Hazm → absorption → Kabid → Istihala → utilisation/storage

The liver (Kabid) occupies a central position in the transformation and distribution of nutritive material.

Modern metabolic science is now showing something remarkably relevant: hepatic fat accumulation, insulin resistance and Type 2 Diabetes are metabolically interconnected. MASLD is recognised as a major hepatic manifestation of metabolic dysfunction, and current guidelines specifically recommend fibrosis risk assessment in people with Type 2 Diabetes or cardiometabolic risk factors.

This creates a potential Meda–Kabid metabolic hypothesis:

Excess / inappropriate dietary load
↓
Su-e-Hazm / disturbed nutritional processing
↓
Excess metabolic substrate reaching the liver
↓
Tashahhum-e-Kabid (hepatic steatosis)
↓
Hepatic insulin resistance
↓
Hyperglycaemia + dyslipidaemia
↓
Type 2 Diabetes / cardiometabolic disease

⚠️ This is not a claim that classical Unani terminology is equivalent to modern molecular pathways.

It is a research hypothesis requiring clinical validation.

Interestingly, the CCRUM Standard Treatment Guidelines already recognise Tashahhum-e-Kabid within the Unani approach to fatty liver and describe therapeutic principles including Islah-e-Su'-e-Mizaj, Tahlil, Tanqiya and Taqwiyat-e-Kabid.

🔬 The research opportunity

Can we clinically test whether a Meda → Kabid → metabolic correction sequence improves:

• Liver fat
• ALT/AST
• HOMA-IR
• HbA1c
• Triglycerides
• Waist circumference
• FIB-4 / fibrosis risk

alongside modern standard care?

That is where Applied Unani Medicine should move next:

Not “Unani versus Modern Medicine.”

But:

Classical concept → modern biomarker → clinical phenotype → measurable outcome → reproducible evidence.

Perhaps Tashahhum-e-Kabid is not merely an old description of fatty liver.

Perhaps it can become a researchable Unani metabolic phenotype.

🌿 From classical Hikmat to measurable metabolic science.

Comments

Post a Comment

Popular posts from this blog

🔰Liver-Centric Cholesterol Regulation

Image
An Applied Unani Perspective in the Era of Gene-Based Lipid Therapy Reframing cholesterol not as a dietary problem, but as a hepatic regulatory signal 🔸Introduction: The Return to a Liver-Centric Model Modern lipid science is increasingly converging on a central idea: cholesterol homeostasis is primarily governed by the liver, not the intestine or diet alone. The emergence of therapies targeting PCSK9, LDL receptors (LDLR), and hepatic gene expression has reinforced this shift. Rather than treating cholesterol as a passive circulating fat, current medicine recognizes it as the outcome of active hepatic regulation of lipid trafficking and clearance. From an Applied Unani standpoint, this resonates strongly with the classical concept of Kabid (liver) as the regulator of Dam (blood quality). Different epistemologies—modern molecular biology and Unani humoral theory—appear to converge on a shared physiological axis: the liver as the center of systemic metabolic governance. 🔸C...
Read more

🔰Why Does Human Temperament Change Throughout Life? A Unani Perspective on the Four Stages of Sinn

Image
Have you ever wondered why a child grows rapidly, a young adult seems almost unstoppable, middle age brings subtle signs of slowing down, and old age naturally comes with reduced strength and resilience? Modern medicine answers this question through genetics, hormones, metabolism, and cellular aging. But centuries before these discoveries, Unani medicine offered its own fascinating explanation. According to classical Unani philosophy, human life is not a fixed biological state but a continuous journey of changing temperament (Mizaj). As we move from childhood to old age, the body's dominant qualities gradually shift in a predictable pattern. These changes are explained through four fundamental qualities: Hararat (heat), Barudat (cold), Rutubat (moisture), and Yubusat (dryness). Rather than viewing aging as a disease, Unani scholars saw it as a natural transformation driven by the interaction between two essential forces: Hararat-e-Ghariziyah (Innate Heat) and Rutubat-e-...
Read more

🔰How Genomics Can Help a Unani Physician in Precise Mizaj Evaluation: A New Frontier of Precision Unani Medicine

Image
🔹From Traditional Mizaj Assessment to Genomic Precision The concept of Mizaj (temperament) is one of the most unique diagnostic foundations of Unani medicine. A Unani physician does not consider disease as an isolated event; rather, disease develops when the individual's inherent biological balance is disturbed. The assessment of Mizaj-e-Insani helps the physician understand susceptibility, lifestyle compatibility, drug response, and disease tendency. Traditionally, Mizaj evaluation is based on clinical observation of multiple parameters: Physical constitution Skin texture and colour Body temperature Sleep pattern Appetite and digestion Emotional characteristics Excretory patterns Response to environmental factors However, in modern clinical practice, physicians face a challenge: How can subjective Mizaj assessment be made more objective, reproducible, and scientifically measurable? Here, genomics opens a new possibility. Applied Unani Genomics does not replace classical Mizaj ass...
Read more